Research programme: vaccines - Sanofi/Maxygen
Alternative Names: Maxy-635; Vaccines research programme - sanofi/MaxygenLatest Information Update: 08 Apr 2022
At a glance
- Originator Maxygen; sanofi pasteur
- Class Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Unspecified
Most Recent Events
- 10 Jun 2013 Discontinued - Preclinical for Undefined indication in France (unspecified route)
- 10 Jun 2013 Discontinued - Preclinical for Undefined indication in USA (unspecified route)
- 21 Jan 2005 Aventis Pasteur is now called sanofi pasteur